Pharmacological treatment of adult ADHD in Europe

References

• Adler LA, Spencer TJ, Milton DR, Moore RJ, Michelson D. 2005. Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis. J Clin Psychiatry 66:294–299.
   PubMed Web of Science ®Google Scholar
• Adler LA, Goodman DW, Kollins SH, Weisler RH, Krishnan S, Zhang Y, . 2008. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 69:1364–1373.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th. Washington, DC: American Psychiatric Association.
   Google Scholar
• Barkley RA. 2002. Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry 63(Suppl 12):10–15.
   PubMed Web of Science ®Google Scholar
• Barkley RA, Fischer M, Smallish L, Fletcher K. 2006. Young adult outcome of hyperactive children; adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 45:92–202.
   Web of Science ®Google Scholar
• Biederman J. 2004. Impact of comorbidity in adults with attentiondeficit/hyperactivity disorder. J Clin Psychiatry 65(Suppl 3):3–7.
   PubMedGoogle Scholar
• Biederman J, Faraone SV. 2006. The effects of attentiondeficit/hyperactivity disorder on employment and household income. Med Gen Med 18:12.
   Google Scholar
• Biederman J, Mick E, Faraone S. 2000. Age-dependent decline of symptoms of attention-deficit hyperactivity disorder: Impact of remission definition and symptome type. Am J Psychiatry 157:816–818.
   PubMed Web of Science ®Google Scholar
• Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, . 2006. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 59:829–835.
   PubMed Web of Science ®Google Scholar
• Bradley C. 1937. The behaviour of children receiving Benzedrine. Am J Psychiatry 94:577–585.
   Google Scholar
• Castells X, Ramos-Quiroga JA, Rigau D, Bosch R, Nogueira M, Vidal X, Casas M. 2011. Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis. CNS Drugs 25:157–169.
   PubMed Web of Science ®Google Scholar
• Ebert D, Krause J, Roth-Sackenheim C and the DGPPN Expert Committee. 2003. [ADHD in adulthood – guidelines based on expert consensus with DGPPN support.] Nervenarzt 74:939–946.
   PubMedGoogle Scholar
• Edel MA, Pfütze EM, Lieder A, Assion HJ, Ribbert H, Juckel G, Brüne M. 2009. Self-concept, action control and ADHD symptoms under methylphenidate treatment in adults with ADHD. Pharmacopsychiatry 42:109–113.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Glatt SJ. 2010. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry 71:754–763.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Sergeant J, Gillberg C, Biederman J. 2003. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2:104–113.
   PubMedGoogle Scholar
• Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J. 2004. Meta-analysis of the efficacy of methylphenidate for treating adult attentiondeficit/hyperactivity disorder. J Clin Psychopharmacol 24:24–39.
   PubMed Web of Science ®Google Scholar
• Fayyad J, De Graf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, . 2007. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402–409.
   PubMed Web of Science ®Google Scholar
• Kaya A, Taner Y, Guclu B, Taner E, Kaya Y, Bahcivan HG, Benli IT. 2008. Trauma and adult attention deficit hyperactivity disorder. J Intern Med Res 36:9–16.
   PubMed Web of Science ®Google Scholar
• Jerome L, Habinski L, Segal A. 2006. Attention deficit/hyperactivity disorder (ADHD) and driving risk: a review of the literature and a methodological critique. Cur Psychiatry Rep 8:416–426.
   PubMedGoogle Scholar
• Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, . 2006. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163:716–723.
   PubMed Web of Science ®Google Scholar
• Koesters M, Becker T, Kilian R, Fegert JM, Weinmann S. 2009. Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. J Psychopharmacol 23:733–744.
   PubMed Web of Science ®Google Scholar
• Marchant BK, Reimherr FW, Robison RJ, Olsen JL, Kondo DG. 2011. Methylphenidate transdermal system in adult ADHD and impact on emotional and oppositional symptoms. J Atten Disord 15:295–304.
   PubMed Web of Science ®Google Scholar
• Mészáros A, Czobor P, B á lint S, Komlósi S, Simon V, Bitter I. 2009. Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. Int J Neuropsychopharmacol 12:1137–1147.
   PubMed Web of Science ®Google Scholar
• Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, . 2003. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 53:112–120.
   PubMed Web of Science ®Google Scholar
• Miller TW, Nigg JT, Faraone SW. 2007. Axis I and II comorbidity in adults with ADHD, J Abnorm Psychol 116:519–528.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence. 2008. Attention deficit hyperactivity disorder: pharmacological and psychological interventions in children, young people and adults [www.NICE.org.uk].
   Google Scholar
• Nutt DJ, Fone K, Asherson P, Bramble D, Hill P, Matthews K, . 2007. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 21:10–41.
   PubMed Web of Science ®Google Scholar
• Reimherr FW, Williams ED, Strong RE, Mestas R, Soni P, Marchant BK. 2007. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiatry 68:93–101.
   Google Scholar
• Retz W, Rösler M. 2011. Association of ADHD with reactive and proactive violent behavior in a forensic population. Atten Defic Hyperact Disord 2:195–202.
   Google Scholar
• Retz W, Rösler M, Ose C, Scherag A, Alm B, Philipsen A, Fischer R, Ammer R. 2010. Multiscale assessment of treatment efficacy in adults with ADHD: A randomized placebo-controlled, multi-centre study with extended-release methylphenidate. World J Biol Psychiatry [Epub ahead of print].
   Web of Science ®Google Scholar
• Rösler M, Retz W, Retz-Junginger P, Hengesch G, Schneider M, Supprian T, . 2004. Prevalence of attention deficit hyperactivity disorder in male young adult prison inmates. Eur Arch Psychiatry Clin Neurosci 254:365–371.
   PubMed Web of Science ®Google Scholar
• Rösler M, Fischer R, Ammer R, Ose C, Retz W. 2009. A randomised, placebo-controlled, 24-week, study of low dose extended-release methylphenidate in adults with attentiondeficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 259:120–129.
   PubMed Web of Science ®Google Scholar
• Rösler M, Casas M, Konofal E, Buitelaar J. 2010a. Attention deficit hyperactivity disorder in adults. World J Biol Psychiatry 11:684–698.
   PubMed Web of Science ®Google Scholar
• Rösler M, Retz W, Fischer R, Ose C, Alm B, Deckert J, . 2010b. Twenty-for-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. World J Biol Psychiatry 11:709–718.
   PubMed Web of Science ®Google Scholar
• Rösler M, Ginsberg Y, Arngrim T, Adamou M, Niemelä A, Dejonkheere J, . 2011. Correlation of symptomatic improvements with functional improvements and patient-reported outcomes in adults with attentiondeficit/hyperactivity disorder treated with OROS methylphenidate. World J Biol Psychiatry [Epub ahead of print].
   Web of Science ®Google Scholar
• Schlander M, Schwarz O, Trott GE, Viapiano M, Bonauer N. 2007. Who cares for patients with attention-deficit/hyperactivity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provísion. Eur Child Adolesc Psychiatry 16:430–438.
   PubMed Web of Science ®Google Scholar
• Scottish Intercollegiate Guidelines Network. 2001. Attention deficit and hyperkinetic disorders in children and young people: a national clinical guideline, Edinburgh, Scotland: SIGN Executive.
   Google Scholar
• Sobanski E, Brüggemann D, Alm B, Kern S, Deschner M, Schubert T, . 2007. Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 257:371–377.
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S. 1996. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 35:409–432.
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Adler LA, McGough JJ, Muniz R, Jiang H, Pestreich L; Adult ADHD Research Group. 2007. Efficacy and safety of dexmeythlphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 61:1380–1387.
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Adler LA, Weisler RH, Youcha SH. 2008. Triplebead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study. J Clin Psychiatry 69:1437–1448.
   PubMed Web of Science ®Google Scholar
• Stein MA. 2004. Innovations in attention-deficit/hyperactivity disorder pharmacotherapy: long-acting stimulant and nonstimulant treatments. Am J Manage Care 10:S89–98.
   PubMed Web of Science ®Google Scholar
• Stiefel G, Besag FM. 2010. Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder. Drug Saf 33:821–842.
   PubMed Web of Science ®Google Scholar
• Weisler RH, Biederman J, Spencer TJ, Wilens TE, Faraone SV, Chrisman AK, Read SC, Tulloch SJ. 2006. Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomised, controlled trial, CNS Spectr 11:625–639.
   PubMed Web of Science ®Google Scholar
• Wender PH. 1995. Attention-deficit hyperactivity disorder in adults. Oxford: New York.
   Google Scholar
• Wender PH, Reimherr FW, Marchant BK, Sanford ME, Czajkowski LA, Tomb DA. 2011. A one year trial of methylphenidate in the treatment of ADHD. J Atten Disord 15:35–45.
   Web of Science ®Google Scholar